Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 5, 1998, Pages 613-620

  Levy, Aaron M ^a   Kita, Hirohito ^a   Phillips, Sidney F ^a   Schkade, Paul A ^b   Dyer, Phillip D ^b   Gleich, Gerald J ^a,c   Dubravec, Vincent A ^b  

^a MAYO CLINIC   (United States)

^b FITZSIMONS ARMY MEDICAL CENTER   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Eosinophil major basic protein; Eosinophil derived neurotoxin; Eosinophilia; Gastrointestinal symptoms; IL 5; Shiitake mushroom

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 5; MAJOR BASIC PROTEIN; NEUROTOXIN;

ADULT; ARTICLE; BLOOD ANALYSIS; EOSINOPHILIA; FECES ANALYSIS; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MUSHROOM; NORMAL HUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0031959977     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70168-X     Document Type: Article

References (35)

1. Morgan C. Shiitake mushroom production gaining ground. Farm-line, USDA, Economic Research Service, 1992;13:16-8.
2. Mori K. Mushrooms as health foods. 1st ed. Tokyo: Japan Publications, Inc.; 1974.
3. Jong SC, Birmingham JM. Medicinal and therapeutic value of the shiitake mushroom. Adv Appl Microbiol 1993;39:153-84.
4. Benjamin DR. Health benefits and medicinal properties of edible mushrooms. Mushrooms: poisons and panaceas, a handbook for naturalists, mycologists, and physicians. New York: W.H. Freeman and Co.; 1995. p. 75-91.
5. Hokama Y , Hokama JL. In vitro inhibition of platelet aggregation with low dalton compounds from aqueous dialysates of edible fungi. Res Commun Chem Pathol Pharmacol 1981;31:177-80.
6. Herberman RB, Nunn-Hargrove ME. Augmentation of natural killer (NK) cell activity by lentinan. In: Aoki T, Tsubura E, Urushizaki I, editors. Manipulation of host defense mechanisms. Amsterdam: Excerpta Medica; 1981. p. 188-93.
7. Suzuki M, Higuchi S, Taki Y, Taki S, Miwa K, Hamuro J. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2. Int J Immunopharmacol 1990;12:613-23.
8. Taguchi T. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect Prevent 1987;Suppl 1:333-49.
9. Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki T. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion. Biotherapy 1992;5:107-12.
10. Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, et al. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 1993;14:671-81.
11. Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997;72:117-23.
12. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 1992;52:611-8.
13. Ohnishi T, Kita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147:901-7.
14. Ide M, Weiler D, Kita H, Gleich GJ. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J Immunol Methods 1994;168:187-96.
15. Yunginger JW, Adolphson CA. Standardization of allergens. In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM, editors. Manual of clinical laboratory immunology. 4th ed. Washington (DC): American Society for Microbiology; 1992. p. 678-84.
16. Swanson MC, Rosanoff E, Gurwith M, Deitch M, Schnurrenberger P, Reed CE. IgE and IgG antibodies to β-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J Infect Dis 1987;155:909-13.
17. Rud F. The eosinophil count in health and in mental disease. A biomedical study. Acta Psychiatr Neurol 1947;Suppl 40:1-443.
18. Beeson PB, Bass DA. The eosinophil. In: Smith LH Jr, editor. Major problems in internal medicine. Vol. 14. Philadelphia: W.B. Saunders; 1977. p. 10-4.
19. Tarvainen K, Salonen J-P, Kanerva L, Estlander T, Keskinen H, Rantanen T. Allergy and toxicoderma from shiitake mushrooms. J Am Acad Dermatol 1991;24:64-6.
20. Ueda A, Obama K, Aoyama K, Ueda T, Xu B-H, Li Q, et al. Allergic contact dermatitis in shiitake (Lentinus edodes (Berk) Sing) growers. Contact Dermatitis 1992;26:228-33.
21. Sastre J, Ibanez MD, Lopez M, Lehrer SB. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin Exp Allergy 1990;20:13-9.
22. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 1992;103:137-45.
23. Teir H, Rytomaa T, Cederberg A, Kiviniemi K. Studies on the elimination of granulocytes in the intestinal tract in rat. Acta Pathol Microbiol Scand 1963;59:311-24.
24. Ross R, Klebanoff SJ. The eosinophilic leukocyte. Fine structure studies of changes in the uterus during the estrous cycle. J Exp Med 1966;124:653-60.
25. Kephart GM, Gleich GJ, Connor DH, Gibson DW, Ackerman SJ. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. Lab Invest 1984;50:51-61.
26. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. N Engl J Med 1985;313:282-5.
27. Weiler CR, Kita H, Hukee M, Gleich GJ. Eosinophil viability during immunoglobulin-induced degranulation. J Leukoc Biol 1996;60:493-501.
28. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
29. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;342:1110-8.
30. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982;2:11-6.
31. Tai P-C, Ackerman SJ, Spry CJF, Dunnette S, Olsen EGJ, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987;1: 643-7.
32. Keshavarzian A, Saverymuttu SH, Tai P-C, Thompson M, Barter S, Spry CJ, et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985;88:1041-9.
33. Levy AM, Sandborn WJ, Burgart LJ, Van Keulen VP, Kephart GM, Tremaine WJ, et al. Eosinophil granule major basic protein is increased in colonie mucosa, serum and urine from patients with ulcerative colitis [abstract]. Gastroenterology 1996;110:949.
34. Levy AM, Burgart LJ, Van Keulen VP, Kephart GM, Phillips SF, Gleich GJ. Eosinophil infiltration and major basic protein deposition are increased in colonic tissue from patients with collagenous colitis [abstract]. Gastroenterology 1996;110:950.
35. Levy AM, Kita H, Sandborn WJ, Phillips SF, Gleich GJ. Eosinophil granule protein concentrations in serum, urine and stool as indicators of disease activity in eosinophilic gastroenteritis [abstract]. Gastroenterology 1996;110:950.